Press Room


Great Success of the "Phase I Clinical Trials in Spain" Session organized by KYMOS and the IFTH

KYMOS is a proud to have been the sponsor and coorganizer of the "Phase I Clinical Trials in Spain" Session. The event took place on June 14 in the Barcelona Sicence Park and had a great success with around 100 attendees. KYMOS' CEO, Joan Puig de Dou, welcomed and farewelled the participants. Other KYMOS team members participate during the event: Lluisa Garcia (COO) moderated a roundtable and Jaume Pascual (Scientific Director Small Molecules) and Carles Celma (Scientific Director Biologics) exhibited very interesting scientific presentations.


Kymos takes part of 57 Simposium AFI at Rimini, June 7-9, 2017

KYMOS participates in the yearly conference of the Italian Association of Industry Pharmacists (AFI) in Rimini. KYMOS and its Italian affiliate PHARMAPROGRESS take up the stand #8 showing up its analytical capabilities in small molecules and biologics.


Kymos coordination of ICH Q3D course in the framework of IL3 UB program

Jaume Pascual, Scientifc Director of Kymos, coordinated a course of IL3 (Barcelona University) about the guideline ICH Q3D on Elemental Impurities. The course took place at Barcelona, the last 1st of June with a lot of success and more of 75 attendants.


Revisions of Medical Device Directives

On 5 April, the European Parliament and the Council are adopted two new Regulations on medical devices: Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices. The new rules will only apply after a